| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,735 |
8,089 |
$775K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,401 |
1,191 |
$160K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,413 |
1,275 |
$144K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,337 |
1,131 |
$125K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
672 |
568 |
$82K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
454 |
415 |
$47K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
1,313 |
1,133 |
$19K |
| 90686 |
|
757 |
720 |
$17K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
160 |
148 |
$8K |
| 90670 |
|
339 |
328 |
$8K |
| 90698 |
|
293 |
286 |
$7K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
125 |
97 |
$6K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
154 |
142 |
$6K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
149 |
122 |
$4K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
13 |
12 |
$4K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
16 |
12 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
398 |
154 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
29 |
28 |
$3K |
| 92551 |
|
329 |
295 |
$3K |
| 90677 |
|
89 |
75 |
$2K |
| 90656 |
|
79 |
77 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
149 |
135 |
$1K |
| 90680 |
|
71 |
68 |
$1K |
| 0072A |
|
25 |
25 |
$1K |
| 0071A |
|
27 |
24 |
$930.36 |
| 96161 |
|
271 |
252 |
$704.26 |
| 96127 |
|
100 |
96 |
$563.45 |
| 83655 |
|
47 |
46 |
$549.32 |
| 99051 |
|
37 |
32 |
$461.30 |
| 90697 |
|
30 |
25 |
$442.32 |
| 99177 |
|
67 |
67 |
$343.27 |
| 90633 |
|
14 |
14 |
$325.92 |
| 87807 |
|
32 |
29 |
$306.04 |
| 90744 |
|
12 |
12 |
$279.36 |
| 85018 |
|
28 |
27 |
$67.45 |
| 99173 |
|
18 |
16 |
$42.12 |
| 96160 |
|
53 |
49 |
$2.84 |
| 36416 |
|
65 |
61 |
$1.50 |
| 91307 |
|
37 |
27 |
$0.23 |
| INVCD |
|
13 |
13 |
$0.00 |